#147—Dr. Carol Nacy Industry: Industry Talk

KGI: Innovation in Applied Life Sciences & Healthcare

In this episode of the KGI podcast, we feature KGI Board of Trustees member Dr. Carol Nacy, who gave an Industry Talk to the KGI community on October 13, 2022.

Nacy is a founder and the Chief Executive Officer of Sequella, Inc., a privately-held pharmaceutical company that discovers and develops treatments for life-threatening infectious diseases. Before Sequella, Nacy was EVP and Chief Scientific Officer at EntreMed, Inc. She left EntreMed to establish Sequella, Inc. and was part-time Chief Scientific Officer for Anergen, Inc., a California company focused on autoimmune diseases. There, she worked with the Management Team to position the company for acquisition by Corixa Corp. Before her business experience, Nacy was a career scientist and science manager for 17 years at Walter Reed Army Institute of Research.

In 2002, Nacy was named a Top 50 Innovator in the U.S. by Inc. Magazine, Entrepreneur of the Year by Women in BIO in 2004, and the state of Maryland named her in its Top 100 Business Women in 2005.